Questions about an order or the RL100 journey?
Contact the HealthspanX support team at support@healthspanx.org.
Contact SupportAbout HealthspanX
HealthspanX created Radiant Life™ to give people a defined starting point, consistent checkpoints, and a completed record—without promising a particular biological outcome.
When the product, timing, or dosage keeps changing, memory is a poor record of what happened.
The design problem behind Radiant Life™
Accountability
HealthspanX was founded by Terry Yang. Sunty LLC is the U.S. brand owner and contracting entity responsible for HealthspanX.
1887 Whitney Mesa Dr. #3088Contact the HealthspanX support team at support@healthspanx.org.
Contact SupportWhy HealthspanX began
Many people begin a supplement routine without documenting a starting point. They may change the product, dosage, timing, sleep, exercise, or other routines, then rely on memory to decide what happened.
Terry created HealthspanX around a more disciplined question: how can a person keep the main variables consistent and retain a structured record of the same self-reported areas over time?
Radiant Life™ is the response: define the program, record the starting point, repeat the same checkpoints, and report the completed comparison without promising the direction of change.
What this means for participants
Keep a defined starting point instead of beginning from memory alone.
Reduce avoidable variation in product, dosage, and checkpoint timing.
Retain a record that can be reviewed after the 100-day window.
See what was recorded without a diagnosis or promised result.
The current program
RL100 combines the current Foundation Protocol with Day 0, Day 30, and Day 100 documentation. Ultra Pure™ NMN is the current Foundation Product. The participant receives a Day 100 Outcome Report comparing the completed record with the locked Day 0 baseline.
Evidence and product discipline
The Evidence Center explains what published studies reported and where their limits apply. Product documentation describes the applicable HealthspanX product and lot. Neither is used to promise what one participant will report.
Plain-language study records with populations, doses, endpoints, limitations, and sources.
Explore the EvidenceCurrent product role, selection framework, product controls, and quality documentation.
Review the Current ProductReview the structure, current Foundation Protocol, age-guided plans, pricing, and 100-day documentation sequence.